Silo Pharma, Inc. (SILO) Q1 2025 Earnings
SILO·Reported May 9, 2025·Before market open
Silo Pharma, Inc. reported Q1 2025 revenue of $18.0K (+0.0% YoY). Diluted EPS came in at $-0.23 (+17.9% YoY).
Revenue
$18.0K
Diluted EPS
$-0.23
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Silo Pharma, Inc.'s Q1 2025 earnings report.
Silo Pharma, Inc. (SILO) reported Q1 2025 earnings on May 9, 2025 before market open.
Silo Pharma, Inc. reported revenue of $18.0K and diluted EPS of $-0.23 for Q1 2025.
Compared to the same quarter a year prior, revenue grew 0.0% from $18.0K a year earlier and diluted EPS grew 17.9% from $-0.28.
You can read the 10-Q periodic report (0001213900-25-041519) directly on SEC EDGAR. The filing index links above go to sec.gov.